Your browser doesn't support javascript.
loading
Evaluation of the maternal and developmental toxicity of 6-methylmercaptopurine riboside in rats.
Gomes-Carneiro, Maria Regina; de Carvalho, Rosângela Ribeiro; do Amaral, Thamyris Figueiredo; Xavier De-Oliveira, Ana Cecilia Amado; Paumgartten, Francisco José Roma.
Afiliação
  • Gomes-Carneiro MR; Laboratory of Environmental Toxicology, National School of Public Health,Oswaldo Cruz Foundation, Rio de Janeiro, RJ 21040-361, Brazil.
  • de Carvalho RR; Laboratory of Environmental Toxicology, National School of Public Health,Oswaldo Cruz Foundation, Rio de Janeiro, RJ 21040-361, Brazil.
  • do Amaral TF; Laboratory of Environmental Toxicology, National School of Public Health,Oswaldo Cruz Foundation, Rio de Janeiro, RJ 21040-361, Brazil.
  • Xavier De-Oliveira ACA; Laboratory of Environmental Toxicology, National School of Public Health,Oswaldo Cruz Foundation, Rio de Janeiro, RJ 21040-361, Brazil.
  • Paumgartten FJR; Laboratory of Environmental Toxicology, National School of Public Health,Oswaldo Cruz Foundation, Rio de Janeiro, RJ 21040-361, Brazil. Electronic address: paum@ensp.fiocruz.br.
Reprod Toxicol ; 111: 158-165, 2022 08.
Article em En | MEDLINE | ID: mdl-35662571
Thiopurine prodrugs (azathioprine, AZA, and 6-mercaptopurine, 6MP) are embryotoxic to rodents and rabbits. Little is known about the developmental toxicity of 6-methylmercaptopurine riboside (6MMPr), a thiopurine drug metabolite that is thought to mediate its liver toxicity. A limb bud assay found that 6MMPr impairs the in vitro morphogenetic differentiation of mouse limb extremities, being more potent than 6MP in the assay. This study evaluated the embryotoxicity of 6MMPr (0, 7.5, 15, 30 mg/kg bw sc) in rats after single-dose exposure in mid organogenesis (GD10). One group of pregnant rats was similarly treated with 6MP (15 mg/kg bw sc). After C-section (GD21), fetuses were weighed, and examined for external abnormalities. One third of each litter was examined for soft-tissue abnormalities while the remaining fetuses were cleared and stained for skeleton evaluation. 6MMPr caused a dose-dependent maternal weight loss followed by recovery before term pregnancy. Except for a nonsignificant increase in embryolethality and slight reduction in fetal weight at 30 mg/kg bw, no indication of embryotoxicity was noted at this dose or at lower doses of 6MMPr. In contrast, 6MP led to nearly 98 % of post-implantation losses in the presence of slight-to-mild maternal toxicity. These results are consistent with the notion that maternal treatment with 6MMPr affects embryo development, causing a nonsignificant increase in embryolethality and a slight reduction in fetal weight at 30 mg/kg bw. However, there was no increase in abnormalities at this dose, which was severely toxic to the dams, as reflected in the maternal weight gain data.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anormalidades Induzidas por Medicamentos / Metiltioinosina Limite: Animals / Pregnancy Idioma: En Revista: Reprod Toxicol Assunto da revista: EMBRIOLOGIA / MEDICINA REPRODUTIVA / TOXICOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anormalidades Induzidas por Medicamentos / Metiltioinosina Limite: Animals / Pregnancy Idioma: En Revista: Reprod Toxicol Assunto da revista: EMBRIOLOGIA / MEDICINA REPRODUTIVA / TOXICOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos